Site Loader
Home

The cannabis market is undergoing a rapid transformation fuelled by accelerating global growth and favourable regulations. These some companies to consider in the coming year:

Aurora Cannabis (ACB)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ‘71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Valuation rating – Undervalued

Fair Value estimate – 18.604

Liquidity – High

Canopy Growth (WEED)

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Valuation rating – Undervalued

Fair Value estimate – 37.785

Liquidity – High

Curaleaf (CURA)

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 23 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company does not currently export into the global medical market as Canadian cannabis producers typically do.

Valuation rating – Fairly Valued

Fair Value estimate – 15.970

Liquidity – High

Tilray (TLRY)

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray’s sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Valuation rating – Undervalued

Fair Value estimate – 13.054

Liquidity – High

Post Author: manacesbusiness

Leave a Reply

Your email address will not be published. Required fields are marked *